Clearstead Trust, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 221 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Clearstead Trust, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$5,072
+11.6%
1010.0%0.00%
+100.0%
Q2 2023$4,5440.0%1010.0%0.00%0.0%
Q1 2023$4,544
+113500.0%
1010.0%0.00%0.0%
Q4 2022$4
-99.9%
1010.0%0.00%
-50.0%
Q3 2022$7,000
+40.0%
1010.0%0.00%
-50.0%
Q2 2022$5,000
-77.3%
101
-71.3%
0.00%
-71.4%
Q1 2022$22,000
-60.0%
352
-31.9%
0.01%
-56.2%
Q4 2021$55,000
+3.8%
5170.0%0.03%
-5.9%
Q3 2021$53,0005170.03%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders